Illumina Body Map 2 (GSE30611)
Name | miRBASE accession |
---|---|
hsa-miR-138-5p
|
MIMAT0000430 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr20_+_10218808 Show fit | 3.12 |
ENST00000254976.7
ENST00000304886.6 |
synaptosome associated protein 25 |
|
chr19_-_49441508 Show fit | 2.89 |
ENST00000221485.8
|
solute carrier family 17 member 7 |
|
chr7_+_31052297 Show fit | 2.72 |
ENST00000304166.9
|
ADCYAP receptor type I |
|
chr15_+_51751587 Show fit | 2.54 |
ENST00000539962.6
ENST00000249700.9 |
tropomodulin 2 |
|
chr5_+_139795795 Show fit | 2.22 |
ENST00000274710.4
|
pleckstrin and Sec7 domain containing 2 |
|
chr17_-_10026265 Show fit | 2.20 |
ENST00000437099.6
ENST00000396115.6 |
growth arrest specific 7 |
|
chr19_+_3880647 Show fit | 2.16 |
ENST00000450849.7
|
ATCAY kinesin light chain interacting caytaxin |
|
chrX_-_103276741 Show fit | 2.10 |
ENST00000372680.2
|
transcription elongation factor A like 5 |
|
chr2_-_100417608 Show fit | 2.05 |
ENST00000264249.8
|
carbohydrate sulfotransferase 10 |
|
chr5_-_176630364 Show fit | 2.00 |
ENST00000310112.7
|
synuclein beta |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.2 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.8 | 3.1 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
1.0 | 2.9 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.0 | 2.8 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 2.7 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 2.7 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.3 | 2.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.5 | 2.2 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.3 | 1.6 | GO:1902162 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) platelet alpha granule organization(GO:0070889) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.1 | 1.6 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 3.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.4 | 3.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.3 | 2.9 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.0 | 2.7 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 2.5 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 2.4 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 2.1 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 1.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 1.5 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 5.0 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 4.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 3.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 3.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 3.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.5 | 2.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 2.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 2.1 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 2.0 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.0 | 2.0 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 2.6 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 1.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 1.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 1.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 1.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 2.7 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 2.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 1.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 1.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 1.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 1.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.9 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |